ActivityDiff: A diffusion model with Positive and Negative Activity Guidance for De Novo Drug Design

• URL: http://arxiv.org/abs/2508.06364v1
• Date: Fri, 08 Aug 2025 14:48:47 GMT
• Title: ActivityDiff: A diffusion model with Positive and Negative Activity Guidance for De Novo Drug Design
• Abstract summary: ActivityDiff is a generative approach based on the classifier-guidance technique of diffusion models.<n>Results show that ActivityDiff effectively handles essential drug design tasks.
• Score: 4.559035716082382
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Achieving precise control over a molecule's biological activity-encompassing targeted activation/inhibition, cooperative multi-target modulation, and off-target toxicity mitigation-remains a critical challenge in de novo drug design. However, existing generative methods primarily focus on producing molecules with a single desired activity, lacking integrated mechanisms for the simultaneous management of multiple intended and unintended molecular interactions. Here, we propose ActivityDiff, a generative approach based on the classifier-guidance technique of diffusion models. It leverages separately trained drug-target classifiers for both positive and negative guidance, enabling the model to enhance desired activities while minimizing harmful off-target effects. Experimental results show that ActivityDiff effectively handles essential drug design tasks, including single-/dual-target generation, fragment-constrained dual-target design, selective generation to enhance target specificity, and reduction of off-target effects. These results demonstrate the effectiveness of classifier-guided diffusion in balancing efficacy and safety in molecular design. Overall, our work introduces a novel paradigm for achieving integrated control over molecular activity, and provides ActivityDiff as a versatile and extensible framework.

Related papers

• ExMolRL: Phenotype-Target Joint Generation of De Novo Molecules via Multi-Objective Reinforcement Learning [4.998189068886174]
  ExMoIRL is a novel generative framework that integrates phenotypic and target-specific cues for de novo molecular generation.<n>It fuses docking affinity and drug-likeness scores, augmented with ranking loss, prior-likelihood regularization, and entropy.<n>Extensive experiments demonstrate ExMoIRL's superior performance over state-of-the-art-based and target-based models.
  arXiv  Detail & Related papers  (2025-09-25T11:13:24Z)
• Fragment-Masked Diffusion for Molecular Optimization [71.13210858056527]
  We propose a fragment-masked molecular optimization method based on phenotypic drug discovery (PDD)<n>PDD-based molecular optimization can reduce potential safety risks while optimizing phenotypic activity, thereby increasing the likelihood of clinical success.<n>The overall experiments demonstrate that the in-silico optimization success rate reaches 95.4%, with an average efficacy increase of 7.5%.
  arXiv  Detail & Related papers  (2024-08-17T06:00:58Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization [49.85944390503957]
  DecompOpt is a structure-based molecular optimization method based on a controllable and diffusion model. We show that DecompOpt can efficiently generate molecules with improved properties than strong de novo baselines.
  arXiv  Detail & Related papers  (2024-03-07T02:53:40Z)
• DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
  Existing structured-based drug design methods treat all ligand atoms equally. We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. Our approach achieves state-of-the-art performance in generating high-affinity molecules.
  arXiv  Detail & Related papers  (2024-02-26T05:21:21Z)
• A biologically-inspired evaluation of molecular generative machine learning [17.623886600638716]
  A novel biologically-inspired benchmark for the evaluation of molecular generative models is proposed. We propose a recreation metric, apply drug-target affinity prediction and molecular docking as complementary techniques for the evaluation of generative outputs.
  arXiv  Detail & Related papers  (2022-08-20T11:01:10Z)
• Bridging the gap between target-based and cell-based drug discovery with a graph generative multi-task model [4.917317902787792]
  Drug discovery is vitally important for protecting human against disease. Target-based screening is one of the most popular methods to develop new drugs in the past several decades. This method efficiently screens candidate drugs inhibiting target protein in vitro, but it often fails due to inadequate activity in vivo. We propose a novel graph multi task deep learning model to identify compounds carrying both target inhibitory and cell active properties.
  arXiv  Detail & Related papers  (2022-08-09T02:35:42Z)
• Target-aware Molecular Graph Generation [37.937378787812264]
  We propose SiamFlow, which forces the flow to fit the distribution of target sequence embeddings in latent space. Specifically, we employ an alignment loss and a uniform loss to bring target sequence embeddings and drug graph embeddings into agreements. Experiments quantitatively show that our proposed method learns meaningful representations in the latent space toward the target-aware molecular graph generation.
  arXiv  Detail & Related papers  (2022-02-10T04:31:14Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics [109.70543391923344]
  CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules. We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations. The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
  arXiv  Detail & Related papers  (2020-05-22T15:57:58Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.